Background: The diversity and non-specificity of the clinical manifestations of opisthorchiasis expands the relevance of this problem and requires an increase in the effectiveness of care for such patients, which necessitates the use of enterosorbents.
Aims: is to analyze the effectiveness of the use of the enterosorbent silicon dioxide colloidal (Polysorb MP) in complex therapy of chronic opisthorchiasis.
Materials and methods: 214 patients with the chronic phase of opisthorchiasis were analyzed (45.3% of women and 54.7% of men aged 18 to 66 years). The diagnosis of opisthorchiasis invasion was confirmed when helminth eggs were found in the feces (in 72.7%), eggs and/or marites of opisthorchiasis in duodenal contents (in 27.3%). Statistical processing was carried out using methods of variational statistics.
Results: The use of the drug Polysorb MP as part of the complex therapy of chronic opisthorchiasis contributes to a faster improvement - the relief of allergic manifestations (when using Polysorb MP amounted to 2.41 (from 2 to 3) days and a significantly significant decrease in total cholesterol and atherogenicity index was noted.
Conclusions: Polysorb MP has shown efficacy in the treatment of patients with opisthorchiasis invasion and disorders in lipid metabolism. Patients noted excellent tolerability and absence of side effects.